Neuralink Lists Blindsight Vision Study as Upcoming Trial

Neuralink’s Blindsight vision-restoration study is listed as an upcoming trial, and the company’s page does not list an active human trial, leaving the program’s clinical timing unspecified. Neuralink founder Elon Musk estimated in June 2025 that the company would perform its first vision implants within six to 12 months. “In the next 6 to 12 months, we'll be doing our first implants for vision,” Musk said. The estimate’s outer end fell around June 2026. On Jan.

Source: TokenPost